Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

22nd Century Group Inc XXII

22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.


NDAQ:XXII - Post by User

Post by khandaanita4444on Sep 26, 2024 10:13am
9 Views
Post# 36242068

$XXII: Pioneering Change in the Tobacco Industry

$XXII: Pioneering Change in the Tobacco Industry
22nd Century Group, Inc. ($XXII) is making significant strides in the evolving landscape of the tobacco industry. Currently distributing its innovative Very Low Nicotine (VLN) products at over 5,100 retail locations, the company is on track to expand into new states soon, enhancing its market reach and accessibility. Analysts project that XXII will reach profitability for its VLN product by Q1 of 2025, marking a pivotal milestone in its growth trajectory.
 
A key differentiator for 22nd Century is its flagship VLN® cigarette, which has made headlines as the world’s first and only combustible cigarette to receive a Modified Risk Tobacco Product (MRTP) designation from the U.S. Food and Drug Administration (FDA). This designation not only underscores the safety of VLN cigarettes but also positions XXII as a trailblazer in a market increasingly focused on reduced harm and safer smoking alternatives.
 
As the demand for healthier smoking options continues to rise, 22nd Century's innovative approach places it in a prime position to lead the charge toward a more responsible tobacco industry. Investors and consumers alike should keep a close watch on XXII as it forges ahead in this transformative space.
<< Previous
Bullboard Posts
Next >>